Literature DB >> 16409187

Cost minimization model for treatment of minor bleeding episodes in inhibitor patients -- methodological issues.

S Seremetis, A V Joshi, M Asmussen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16409187     DOI： 10.1111/j.1365-2516.2006.01163.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  1 in total

Review 1.  Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.

Authors:  Katherine A Lyseng-Williamson; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.